SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects

被引：120
作者：
Lam, Carolyn S. P. [1 ,2 ,3 ,4 ]
Chandramouli, Chanchal [1 ]
Ahooja, Vineeta [5 ]
Verma, Subodh [6 ,7 ]
机构：
[1] Natl Heart Ctr Singapore, 5 Hosp Dr, Singapore 169609, Singapore
[2] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] George Inst Global Hlth, Newtown, Tas, Australia
[5] Heart Hlth Inst, Toronto, ON, Canada
[6] Univ Toronto, Keenan Res Ctr Biomed Sci, Div Cardiac Surg, St Michaels Hosp, Toronto, ON, Canada
[7] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 20期
关键词：
heart failure; SGLT-2; inhibitors; type 2 diabetes mellitus; unmet needs; ASSOCIATION TASK-FORCE; 2013 ACCF/AHA GUIDELINE; NONCARDIAC COMORBIDITIES; CARDIOVASCULAR OUTCOMES; AMERICAN-COLLEGE; DIABETES-MELLITUS; EJECTION FRACTION; NA+/H+-EXCHANGER; CARDIAC FIBROSIS; FOCUSED UPDATE;
D O I：
10.1161/JAHA.119.013389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：12
相关论文
共 102 条
  • [1] Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes
    Al-Jobori, Hussein
    Daniele, Giuseppe
    Cersosimo, Eugenio
    Triplitt, Curtis
    Mehta, Rucha
    Norton, Luke
    DeFronzo, Ralph A.
    Abdul-Ghani, Muhammad
    [J]. DIABETES, 2017, 66 (07) : 1999 - 2006
  • [2] [Anonymous], 2016, NAT HEART FAIL AUD 2
  • [3] Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Zachariah, Amit A.
    Wehrens, Xander H. T.
    Deswal, Anita
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 998 - 1005
  • [4] Chronic inhibition of the Na+/H+-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling
    Baartscheer, A.
    Hardziyenka, M.
    Schumacher, C. A.
    Belterman, C. N. W.
    van Borren, M. M. G. J.
    Verkerk, A. O.
    Coronel, R.
    Fiolet, J. W. T.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (06) : 1266 - 1275
  • [5] Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
    Baartscheer, Antonius
    Schumacher, Cees A.
    Wust, Rob C. I.
    Fiolet, Jan W. T.
    Stienen, Ger J. M.
    Coronel, Ruben
    Zuurbier, Coert J.
    [J]. DIABETOLOGIA, 2017, 60 (03) : 568 - 573
  • [6] Bloom DE., 2011, The global economic burden of noncommunicable diseases
  • [7] Bonaca MP, 2019, 68 ANN SCI SESS EXP
  • [8] Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
    Bonner, Caroline
    Kerr-Conte, Julie
    Gmyr, Valery
    Queniat, Gurvan
    Moerman, Ericka
    Thevenet, Julien
    Beaucamps, Cedric
    Delalleau, Nathalie
    Popescu, Iuliana
    Malaisse, Willy J.
    Sener, Abdullah
    Deprez, Benoit
    Abderrahmani, Amar
    Staels, Bart
    Pattou, Francois
    [J]. NATURE MEDICINE, 2015, 21 (05) : 512 - U139
  • [9] Byrne Nikole J, 2017, JACC Basic Transl Sci, V2, P347, DOI 10.1016/j.jacbts.2017.07.003
  • [10] Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry
    Cavender, Matthew A.
    Steg, Ph Gabriel
    Smith, Sidney C., Jr.
    Eagle, Kim
    Ohman, E. Magnus
    Goto, Shinya
    Kuder, Julia
    Im, Kyungah
    Wilson, Peter W. F.
    Bhatt, Deepak L.
    [J]. CIRCULATION, 2015, 132 (10) : 923 - 931
12345678910